SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001078782-20-000230
Filing Date
2020-04-01
Accepted
2020-04-01 16:12:52
Documents
7
Period of Report
2020-04-01

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT pre14a033020_pre14a.htm PRE 14A 680070
2 IMAGE pre14a033020pre14a1.jpg GRAPHIC 308179
3 IMAGE pre14a033020pre14a2.jpg GRAPHIC 408414
4 IMAGE pre14a033020pre14a3.jpg GRAPHIC 135369
5 IMAGE pre14a033020pre14a4.jpg GRAPHIC 229251
6 IMAGE pre14a033020pre14a5.jpg GRAPHIC 147783
7 IMAGE pre14a033020pre14a6.jpg GRAPHIC 31364
  Complete submission text file 0001078782-20-000230.txt   2417237
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36833 | Film No.: 20765525
SIC: 2835 In Vitro & In Vivo Diagnostic Substances